Defining relative androgen deficiency in aging men: how should testosterone be measured and what are the relationships between androgen levels and physical, sexual and emotional health?

被引:31
作者
Haren, MT
Morley, JE
Chapman, IM
O'Loughlin, PD
Wittert, GA
机构
[1] Univ Adelaide, Royal Adelaide Hosp, Dept Med, Adelaide, SA 5000, Australia
[2] St Louis Univ, Div Geriatr Med, St Louis, MO 63103 USA
[3] Vet Affairs Med Ctr, GRECC, St Louis, MO USA
[4] Inst Med & Vet Sci, Div Clin Biochem, Adelaide, SA 5000, Australia
关键词
testosterone; men; aging; muscle strength; body composition; cognitive function; libido;
D O I
10.1080/713605195
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
In men, bioavailable and free testosterone levels decline by about 1.0 and 1.2% per year, respectively, after the age of 40. The definition of clinically relevant androgen deficiency in the aging male remains uncertain. Clinical features common to both aging and androgen deficiency include decreased muscle mass and strength, and increased fatigue, increased fat mass, loss of libido, erectile dysfunction, impaired cognitive function and depression. It is, however, difficult to separate the effect on plasma testosterone of concomitant disease, compared with the effects of a decrease in testosterone levels alone. Testosterone supplementation has been shown to be effective in improving many of the clinical features of androgen deficiency in the older male, and is safe, at least in the short term. The maximum benefit occurs in those men with the lowest testosterone levels.
引用
收藏
页码:15 / 25
页数:11
相关论文
共 94 条
  • [11] Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men - A Clinical research center study
    Brodsky, IG
    Balagopal, P
    Nair, KS
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (10) : 3469 - 3475
  • [12] BURRIS AS, 1992, J ANDROL, V13, P297
  • [13] Hormonal and biochemical parameters in the determination of osteoporosis in elderly men
    Center, JR
    Nguyen, TV
    Sambrook, PN
    Eisman, JA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (10) : 3626 - 3635
  • [14] Difficulties in measuring the effect of testosterone replacement therapy on muscle function in older men
    Clague, JE
    Wu, FCW
    Horan, MA
    [J]. INTERNATIONAL JOURNAL OF ANDROLOGY, 1999, 22 (04): : 261 - 265
  • [15] EFFECT OF EXOGENOUS TESTOSTERONE REPLACEMENT ON PROSTATE-SPECIFIC ANTIGEN AND PROSTATE-SPECIFIC MEMBRANE ANTIGEN LEVELS IN HYPOGONADAL MEN
    DOUGLAS, TH
    CONNELLY, RR
    MCLEOD, DG
    ERICKSON, SJ
    BARREN, R
    MURPHY, GP
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 1995, 59 (04) : 246 - 250
  • [16] Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies
    Eaton, NE
    Reeves, GK
    Appleby, PN
    Key, TJ
    [J]. BRITISH JOURNAL OF CANCER, 1999, 80 (07) : 930 - 934
  • [17] Long-term testosterone administration increases visceral fat in female to male transsexuals
    Elbers, JMH
    Asscheman, H
    Seidell, JC
    Megens, JAJ
    Gooren, LJG
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (07) : 2044 - 2047
  • [18] ELLYIN FM, 1995, 77 ANN M END SOC US
  • [19] Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men
    Falahati-Nini, A
    Riggs, BL
    Atkinson, EJ
    O'Fallon, WM
    Eastell, R
    Khosla, S
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (12) : 1553 - 1560
  • [20] Ferrini RL, 1998, AM J EPIDEMIOL, V147, P750